1Nacumov NV, Rossol S.Studies of interleukin- 12 in chronic hepatitis B virus infection[J] .J Viral Hepat. 1997,4 Suppl 2:87.
2Kobayashi M, Filz L, Ryan M,et al. Identification and purifieation of natanal killer cell stirculatory factor (NKSF), a cytokine with multiple biologic: effects on human lymphocytes [J] .J Exp Med. 1989,170:827.
3Stem AS, Podlaski FJ,Hulmes JD,et al.Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation from human B lymphoblastoid cells[J].Proc Nail Acad Sei USA. 1990,87:6808.
4Carreno V,Quirogu JA. Biological progperties of Imterleukin 12 and its therapetitie use in peristent hepatitis B virus and hepatitis C virus infection [J].J Viral Hepst,1997,4 Suppl 2:83.
5Milich DR. lnfluence of T - helper cell subsets and erussregulstion in hepatitis B virus infection[J] .J Viral. Hepat, 1997,4 Supp12:48.
6Cavanaugh VJ,Guidotti LG,Chisari FV.Interleukin 12 inhibits hepatitis B virus repliestion in tranagenic mice[J].J Virol, 1997,71 (4) :3236.
7Vingorhoets J,Michielsen P,Vanlam G,et al. HBV- specific lyrphoproliferative and cytokine respcnses in patients with chronic hepatitis B[J] .J Hepatol, 1998,28(1) :8.
8Rossol S,Marinos G, Carucci P, et al.Intertleukin- 12 induction of Th1 eytokines in important for viral clearance in chronic hepatitis B[J] .J Clin Invest, 1997,99(12) : 3025.
9Chow YH, Chiang BL,Lee YL, et al. Development of Th1 and Th2 populations and the nature of immune responses to hepstits B virus DNA vaceines can be modulated by codelivery of various cytokine genes[J] .J Immunol,1998,160( 3 ) : 1320.
10Villarrubia VG. Alvarez Mon M, Chirigos MA. et al. Hepatitis B virus (HBV)and the inflanmatory/immune response. (l).The natural environment of the antigen presentation and immunologic chsos induced by the virus [J].Rev Esp Enferm Dig, 1997,89(12):919.
